Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Feb 2026 and Mar 2026.
- Largest single sale: $1.2M (14,505 shares) of Kymera Therapeutics, Inc. on Dec 17, 2025. Filing
- Last sale before this period: Jun 3, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Director | Sep 9, 2020 | Jun 25, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 19, 2026, Kymera Therapeutics, Inc.: 1,000 shares acquired by exercising options. 1 filing: 1
- Mar 20, 2026, Kymera Therapeutics, Inc.: sold 2,500 shares for $198K, under a disclosed plan; 2,500 shares acquired by exercising options. 1 filing: 1
- Feb 20, 2026, Kymera Therapeutics, Inc.: sold 2,500 shares for $218K, under a disclosed plan; 2,500 shares acquired by exercising options. 1 filing: 1
- Jan 20, 2026, Kymera Therapeutics, Inc.: sold 5,500 shares for $374K, under a disclosed plan; 5,500 shares acquired by exercising options. 1 filing: 1
- Dec 17, 2025, Kymera Therapeutics, Inc.: sold 27,563 shares for $2.3M, under a disclosed plan; 27,563 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.